Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511719
Status:
COMPLETED
Last Update Posted:
2011-06-29
First Post:
2007-08-03
Brief Title:
Bioavailability of Technosphere Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes
Sponsor:
Mannkind Corporation
Organization:
Mannkind Corporation
Study Overview
Official Title:
A Prospective Controlled Single-Center Open-LabelRandomized Replicated Crossover Isoglycemic Glucose Clamp Study Evaluating Intrapatient Variability in Bioavailability of Technosphere Insulin Compared With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the kinetics and biodynamics of inhaled Technosphere Insulin with those of subcutaneous SC regular human insulin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None